Compass Wealth Management LLC purchased a new position in shares of Align Technology, Inc. (NASDAQ:ALGN - Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 55,709 shares of the medical equipment provider's stock, valued at approximately $7,377,000. Align Technology makes up approximately 1.4% of Compass Wealth Management LLC's portfolio, making the stock its 17th largest position. Compass Wealth Management LLC owned approximately 0.08% of Align Technology at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. BlackRock Inc. purchased a new position in shares of Align Technology in the second quarter valued at $745,370,000. Assenagon Asset Management S.A. boosted its position in Align Technology by 638.7% in the 3rd quarter. Assenagon Asset Management S.A. now owns 4,662,437 shares of the medical equipment provider's stock valued at $629,469,000 after buying an additional 4,031,284 shares during the last quarter. Vontobel Holding Ltd. boosted its position in Align Technology by 69,628.9% in the 3rd quarter. Vontobel Holding Ltd. now owns 1,385,513 shares of the medical equipment provider's stock valued at $183,335,000 after buying an additional 1,383,526 shares during the last quarter. Deutsche Bank AG acquired a new stake in shares of Align Technology during the second quarter valued at about $99,779,000. Finally, Bank of America Corp DE acquired a new stake in shares of Align Technology during the second quarter valued at about $93,085,000. Hedge funds and other institutional investors own 88.43% of the company's stock.
Align Technology Stock Up 2.7%
NASDAQ:ALGN opened at $155.51 on Friday. The company has a market cap of $11.14 billion, a PE ratio of 16.76, a P/E/G ratio of 1.62 and a beta of 1.67. The business's 50 day moving average is $152.16 and its two-hundred day moving average is $166.63. Align Technology, Inc. has a 52 week low of $130.23 and a 52 week high of $200.43.
Align Technology (NASDAQ:ALGN - Get Free Report) last issued its quarterly earnings results on Wednesday, July 29th. The medical equipment provider reported $2.64 earnings per share for the quarter, beating analysts' consensus estimates of $2.62 by $0.02. The business had revenue of $1.06 billion during the quarter, compared to the consensus estimate of $1.05 billion. Align Technology had a return on equity of 15.86% and a net margin of 9.99%. The business's quarterly revenue was up 4.3% on a year-over-year basis. During the same period in the previous year, the business earned $2.49 EPS. As a group, sell-side analysts expect that Align Technology, Inc. will post 9.34 EPS for the current fiscal year.
Analysts Set New Price Targets
ALGN has been the topic of a number of analyst reports. BMO Capital Markets started coverage on Align Technology in a research report on Wednesday, July 8th. They set an "outperform" rating and a $209.00 target price on the stock. Mizuho reduced their price target on Align Technology from $220.00 to $200.00 and set an "outperform" rating for the company in a report on Thursday. Needham & Company LLC restated a "hold" rating on shares of Align Technology in a research note on Thursday, July 30th. UBS Group restated a "neutral" rating and set a $189.00 price objective on shares of Align Technology in a research note on Thursday, July 23rd. Finally, Leerink Partners dropped their price objective on Align Technology from $235.00 to $215.00 and set an "outperform" rating on the stock in a report on Wednesday, October 14th. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $190.93.
Get Our Latest Analysis on Align Technology
About Align Technology
(
Free Report)
Align Technology, Inc is a global medical device company focused on digital orthodontics and restorative dentistry. Founded in 1997, the company is best known for the Invisalign system, a series of clear, removable aligners designed to gradually move teeth and treat a range of orthodontic conditions.
Align's products and services also include digital scanning and dental practice solutions. Its iTero intraoral scanners create digital impressions for orthodontic and restorative procedures, while its exocad business develops computer-aided design and computer-aided manufacturing software used by dental laboratories, clinicians and other dental professionals.
The company serves orthodontists, dentists, dental laboratories and patients in numerous markets worldwide.
Featured Articles
Want to see what other hedge funds are holding ALGN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Align Technology, Inc. (NASDAQ:ALGN - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Align Technology, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Align Technology wasn't on the list.
While Align Technology currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Oil still powers the global economy, but AI is reshaping the energy opportunity. Discover seven stocks spanning traditional energy, infrastructure, and next-generation power.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.